BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mukhopadhyay A, Banerjee S, Stafford LJ, Xia C, Liu M, Aggarwal BB. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene. 2002;21:8852-8861. [PMID: 12483537 DOI: 10.1038/sj.onc.1206048] [Cited by in Crossref: 229] [Cited by in F6Publishing: 216] [Article Influence: 12.1] [Reference Citation Analysis]
Number Citing Articles
1 Hosseini S, Chamani J, Sinichi M, Bonakdar AM, Azad Z, Ahangari N, Rahimi HR. The effect of nanomicelle curcumin, sorafenib, and combination of the two on the cyclin D1 gene expression of the hepatocellular carcinoma cell line (HUH7). Iran J Basic Med Sci 2019;22:1198-202. [PMID: 31998463 DOI: 10.22038/ijbms.2019.35808.8530] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Balasubramanian S, Eckert RL. Green tea polyphenol and curcumin inversely regulate human involucrin promoter activity via opposing effects on CCAAT/enhancer-binding protein function. J Biol Chem. 2004;279:24007-24014. [PMID: 15044435 DOI: 10.1074/jbc.M314331200] [Cited by in Crossref: 51] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
3 Heng MC. Signaling pathways targeted by curcumin in acute and chronic injury: burns and photo-damaged skin. Int J Dermatol 2013;52:531-43. [PMID: 23231506 DOI: 10.1111/j.1365-4632.2012.05703.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
4 Marjaneh RM, Rahmani F, Hassanian SM, Rezaei N, Hashemzehi M, Bahrami A, Ariakia F, Fiuji H, Sahebkar A, Avan A, Khazaei M. Phytosomal curcumin inhibits tumor growth in colitis‐associated colorectal cancer. J Cell Physiol 2018;233:6785-98. [DOI: 10.1002/jcp.26538] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 12.3] [Reference Citation Analysis]
5 He Y, Liu X. The tumor-suppressor gene LZTS1 suppresses hepatocellular carcinoma proliferation by impairing PI3K/Akt pathway. Biomedicine & Pharmacotherapy 2015;76:141-6. [DOI: 10.1016/j.biopha.2015.10.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
6 Usta M, Wortelboer HM, Vervoort J, Boersma MG, Rietjens IM, van Bladeren PJ, Cnubben NH. Human glutathione S-transferase-mediated glutathione conjugation of curcumin and efflux of these conjugates in Caco-2 cells. Chem Res Toxicol 2007;20:1895-902. [PMID: 17975885 DOI: 10.1021/tx7002245] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
7 Shimada K, Ushijima K, Suzuki C, Horiguchi M, Ando H, Akita T, Shimamura M, Fujii J, Yamashita C, Fujimura A. Pulmonary administration of curcumin inhibits B16F10 melanoma lung metastasis and invasion in mice. Cancer Chemother Pharmacol 2018;82:265-73. [PMID: 29869202 DOI: 10.1007/s00280-018-3616-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
8 Aggarwal BB, Takada Y, Oommen OV. From chemoprevention to chemotherapy: common targets and common goals. Expert Opin Investig Drugs. 2004;13:1327-1338. [PMID: 15461561 DOI: 10.1517/13543784.13.10.1327] [Cited by in Crossref: 118] [Cited by in F6Publishing: 106] [Article Influence: 7.4] [Reference Citation Analysis]
9 Tsuiji K, Takeda T, Li B, Wakabayashi A, Kondo A, Kimura T, Yaegashi N. Inhibitory effect of curcumin on uterine leiomyoma cell proliferation. Gynecol Endocrinol 2011;27:512-7. [PMID: 20672906 DOI: 10.3109/09513590.2010.507287] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
10 Plyduang T, Armiñán A, Movellan J, England RM, Wiwattanapatapee R, Vicent MJ. Polyacetal-Based Combination Therapy for the Treatment of Prostate Cancer. Macromol Rapid Commun 2018;39:1800265. [DOI: 10.1002/marc.201800265] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Hashemzehi M, Behnam‐rassouli R, Hassanian SM, Moradi‐binabaj M, Moradi‐marjaneh R, Rahmani F, Fiuji H, Jamili M, Mirahmadi M, Boromand N, Piran M, Jafari M, Sahebkar A, Avan A, Khazaei M. Phytosomal‐curcumin antagonizes cell growth and migration, induced by thrombin through AMP‐Kinase in breast cancer. J Cell Biochem 2018;119:5996-6007. [DOI: 10.1002/jcb.26796] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
12 Takada Y, Murakami A, Aggarwal BB. Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene 2005;24:6957-69. [PMID: 16007145 DOI: 10.1038/sj.onc.1208845] [Cited by in Crossref: 135] [Cited by in F6Publishing: 117] [Article Influence: 8.4] [Reference Citation Analysis]
13 Khan M, Maryam A, Zhang H, Mehmood T, Ma T. Killing cancer with platycodin D through multiple mechanisms. J Cell Mol Med 2016;20:389-402. [PMID: 26648178 DOI: 10.1111/jcmm.12749] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 7.0] [Reference Citation Analysis]
14 Sun X, Wang M, Zhang F, Kong X. Inhibition of NET-1 suppresses proliferation and promotes apoptosis of hepatocellular carcinoma cells by activating the PI3K/AKT signaling pathway. Exp Ther Med 2019;17:2334-40. [PMID: 30867719 DOI: 10.3892/etm.2019.7211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Alao JP. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer. 2007;6:24. [PMID: 17407548 DOI: 10.1186/1476-4598-6-24] [Cited by in Crossref: 469] [Cited by in F6Publishing: 464] [Article Influence: 31.3] [Reference Citation Analysis]
16 Orteca G, Pisaneschi F, Rubagotti S, Liu TW, Biagiotti G, Piwnica-Worms D, Iori M, Capponi PC, Ferrari E, Asti M. Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies. Molecules 2019;24:E644. [PMID: 30759785 DOI: 10.3390/molecules24030644] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
17 Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, Limtrakul P, Badmaev V, Aggarwal BB. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis. 2007;28:1765-1773. [PMID: 17522064 DOI: 10.1093/carcin/bgm123] [Cited by in Crossref: 373] [Cited by in F6Publishing: 348] [Article Influence: 24.9] [Reference Citation Analysis]
18 Wang Y, Yin H, Wang L, Shuboy A, Lou J, Han B, Zhang X, Li J. Curcumin as a potential treatment for Alzheimer's disease: a study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein. Am J Chin Med 2013;41:59-70. [PMID: 23336507 DOI: 10.1142/S0192415X13500055] [Cited by in Crossref: 48] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
19 Sager RA, Backe SJ, Ahanin E, Smith G, Nsouli I, Woodford MR, Bratslavsky G, Bourboulia D, Mollapour M. Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma. Nat Rev Urol 2022. [PMID: 35264774 DOI: 10.1038/s41585-022-00571-8] [Reference Citation Analysis]
20 Sun Y, Liu L, Wang Y, He A, Hu H, Zhang J, Han M, Huang Y. Curcumin inhibits the proliferation and invasion of MG-63 cells through inactivation of the p-JAK2/p-STAT3 pathway. Onco Targets Ther 2019;12:2011-21. [PMID: 30936718 DOI: 10.2147/OTT.S172909] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
21 Farajipour H, Rahimian S, Taghizadeh M. Curcumin: A new candidate for retinal disease therapy? J Cell Biochem 2018. [PMID: 30548307 DOI: 10.1002/jcb.28068] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
22 Bharti AC, Donato N, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol. 2003;171:3863-3871. [PMID: 14500688 DOI: 10.4049/jimmunol.171.7.3863] [Cited by in Crossref: 345] [Cited by in F6Publishing: 309] [Article Influence: 19.2] [Reference Citation Analysis]
23 Moon D, Kim M, Kang S, Choi YH, Park SY, Kim G. HA14-1 sensitizes TNF-α-induced apoptosis via inhibition of the NF-κB signaling pathway: Involvement of reactive oxygen species and JNK. Cancer Letters 2010;292:111-8. [DOI: 10.1016/j.canlet.2009.11.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
24 Gao X, Kuo J, Jiang H, Deeb D, Liu Y, Divine G, Chapman RA, Dulchavsky SA, Gautam SC. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol. 2004;68:51-61. [PMID: 15183117 DOI: 10.1016/j.bcp.2004.03.015] [Cited by in Crossref: 111] [Cited by in F6Publishing: 102] [Article Influence: 6.2] [Reference Citation Analysis]
25 Mondal G, Barui S, Saha S, Chaudhuri A. Tumor growth inhibition through targeting liposomally bound curcumin to tumor vasculature. Journal of Controlled Release 2013;172:832-40. [DOI: 10.1016/j.jconrel.2013.08.302] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
26 Sandur SK, Ichikawa H, Pandey MK, Kunnumakkara AB, Sung B, Sethi G, Aggarwal BB. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 2007;43:568-80. [PMID: 17640567 DOI: 10.1016/j.freeradbiomed.2007.05.009] [Cited by in Crossref: 184] [Cited by in F6Publishing: 172] [Article Influence: 12.3] [Reference Citation Analysis]
27 Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol. 2005;70:700-713. [PMID: 16023083 DOI: 10.1016/j.bcp.2005.04.043] [Cited by in Crossref: 323] [Cited by in F6Publishing: 314] [Article Influence: 19.0] [Reference Citation Analysis]
28 Bhandarkar SS, Arbiser JL. Curcumin as an inhibitor of angiogenesis. Adv Exp Med Biol 2007;595:185-95. [PMID: 17569211 DOI: 10.1007/978-0-387-46401-5_7] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
29 Imran M, Ullah A, Saeed F, Nadeem M, Arshad MU, Suleria HAR. Cucurmin, anticancer, & antitumor perspectives: A comprehensive review. Crit Rev Food Sci Nutr. 2018;58:1271-1293. [PMID: 27874279 DOI: 10.1080/10408398.2016.1252711] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
30 Mani J, Kumar S, Dobos GJ, Haferkamp A. [Aspects of traditional Indian medicine (Ayurveda) in urology]. Urologe A 2012;51:1663-73. [PMID: 23178846 DOI: 10.1007/s00120-012-3063-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Takada Y, Kobayashi Y, Aggarwal BB. Evodiamine Abolishes Constitutive and Inducible NF-κB Activation by Inhibiting IκBα Kinase Activation, Thereby Suppressing NF-κB-regulated Antiapoptotic and Metastatic Gene Expression, Up-regulating Apoptosis, and Inhibiting Invasion. Journal of Biological Chemistry 2005;280:17203-12. [DOI: 10.1074/jbc.m500077200] [Cited by in Crossref: 123] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
32 Batie S, Lee JH, Jama RA, Browder DO, Montano LA, Huynh CC, Marcus LM, Tsosie DG, Mohammed Z, Trang V, Marshall PA, Jurutka PW, Wagner CE. Synthesis and biological evaluation of halogenated curcumin analogs as potential nuclear receptor selective agonists. Bioorg Med Chem 2013;21:693-702. [PMID: 23276449 DOI: 10.1016/j.bmc.2012.11.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
33 Van Erk MJ, Teuling E, Staal YC, Huybers S, Van Bladeren PJ, Aarts JM, Van Ommen B. Time- and dose-dependent effects of curcumin on gene expression in human colon cancer cells. J Carcinog 2004;3:8. [PMID: 15140256 DOI: 10.1186/1477-3163-3-8] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 3.2] [Reference Citation Analysis]
34 Collett GP, Campbell FC. Overexpression of p65/RelA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells. Carcinogenesis 2006;27:1285-91. [DOI: 10.1093/carcin/bgi368] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
35 Gulei D, Mehterov N, Nabavi SM, Atanasov AG, Berindan-neagoe I. Targeting ncRNAs by plant secondary metabolites: The ncRNAs game in the balance towards malignancy inhibition. Biotechnology Advances 2018;36:1779-99. [DOI: 10.1016/j.biotechadv.2017.11.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
36 Beevers CS, Li F, Liu L, Huang S. Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells. Int J Cancer 2006;119:757-64. [PMID: 16550606 DOI: 10.1002/ijc.21932] [Cited by in Crossref: 160] [Cited by in F6Publishing: 151] [Article Influence: 10.0] [Reference Citation Analysis]
37 Srivastava RM, Singh S, Dubey SK, Misra K, Khar A. Immunomodulatory and therapeutic activity of curcumin. Int Immunopharmacol. 2011;11:331-341. [PMID: 20828642 DOI: 10.1016/j.intimp.2010.08.014] [Cited by in Crossref: 124] [Cited by in F6Publishing: 115] [Article Influence: 10.3] [Reference Citation Analysis]
38 Wang J, Wei H, Huang Y, Chen D, Zeng G, Lian Y, Huang Y. The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells. Aging (Albany NY) 2019;11:5769-85. [PMID: 31409760 DOI: 10.18632/aging.102165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Choudhuri T, Pal S, Das T, Sa G. Curcumin Selectively Induces Apoptosis in Deregulated Cyclin D1-expressed Cells at G2 Phase of Cell Cycle in a p53-dependent Manner. Journal of Biological Chemistry 2005;280:20059-68. [DOI: 10.1074/jbc.m410670200] [Cited by in Crossref: 211] [Cited by in F6Publishing: 85] [Article Influence: 12.4] [Reference Citation Analysis]
40 Hallman K, Aleck K, Dwyer B, Lloyd V, Quigley M, Sitto N, Siebert AE, Dinda S. The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells. Breast Cancer (Dove Med Press) 2017;9:153-61. [PMID: 28331366 DOI: 10.2147/BCTT.S125783] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
41 Enyeart JA, Liu H, Enyeart JJ. Curcumin inhibits bTREK-1 K+ channels and stimulates cortisol secretion from adrenocortical cells. Biochem Biophys Res Commun 2008;370:623-8. [PMID: 18406348 DOI: 10.1016/j.bbrc.2008.04.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
42 Balasubramanian S, Zhu L, Eckert RL. Apigenin Inhibition of Involucrin Gene Expression Is Associated with a Specific Reduction in Phosphorylation of Protein Kinase Cδ Tyr311. Journal of Biological Chemistry 2006;281:36162-72. [DOI: 10.1074/jbc.m605368200] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
43 Ryu MJ, Cho M, Song JY, Yun YS, Choi IW, Kim DE, Park BS, Oh S. Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem Biophys Res Commun. 2008;377:1304-1308. [PMID: 19000900 DOI: 10.1016/j.bbrc.2008.10.171] [Cited by in Crossref: 102] [Cited by in F6Publishing: 88] [Article Influence: 7.3] [Reference Citation Analysis]
44 Mapoung S, Suzuki S, Fuji S, Naiki-Ito A, Kato H, Yodkeeree S, Sakorn N, Ovatlarnporn C, Takahashi S, Limtrakul Dejkriengkraikul P. Dehydrozingerone, a Curcumin Analog, as a Potential Anti-Prostate Cancer Inhibitor In Vitro and In Vivo. Molecules 2020;25:E2737. [PMID: 32545675 DOI: 10.3390/molecules25122737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
45 Weir NM, Selvendiran K, Kutala VK, Tong L, Vishwanath S, Rajaram M, Tridandapani S, Anant S, Kuppusamy P. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther 2007;6:178-84. [PMID: 17218783 DOI: 10.4161/cbt.6.2.3577] [Cited by in Crossref: 191] [Cited by in F6Publishing: 181] [Article Influence: 12.7] [Reference Citation Analysis]
46 Glienke W, Maute L, Wicht J, Bergmann L. Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression. Cancer Invest. 2010;28:166-171. [PMID: 20121547 DOI: 10.3109/07357900903287006] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 6.8] [Reference Citation Analysis]
47 Karim S, Al-Maghrabi JA, Farsi HM, Al-Sayyad AJ, Schulten HJ, Buhmeida A, Mirza Z, Al-Boogmi AA, Ashgan FT, Shabaad MM, NourEldin HF, Al-Ghamdi KB, Abuzenadah A, Chaudhary AG, Al-Qahtani MH. Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia. BMC Cancer 2016;16:741. [PMID: 27766950 DOI: 10.1186/s12885-016-2775-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
48 Xinjian L, Xiaocheng L. Effect of curcumin on immune function of mice. J Huazhong Univ Sci Technol [Med Sci ] 2005;25:137-40. [DOI: 10.1007/bf02873559] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
49 Kanai M, Yoshimura K, Asada M, Imaizumi A, Suzuki C, Matsumoto S, Nishimura T, Mori Y, Masui T, Kawaguchi Y. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol. 2011;68:157-164. [PMID: 20859741 DOI: 10.1007/s00280-010-1470-2] [Cited by in Crossref: 239] [Cited by in F6Publishing: 221] [Article Influence: 19.9] [Reference Citation Analysis]
50 Mahendran R, Lim SK, Ong KC, Chua KH, Chai HC. Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatment. Clin Exp Nephrol 2021. [PMID: 34254206 DOI: 10.1007/s10157-021-02111-x] [Reference Citation Analysis]
51 Bhullar KS, Lagarón NO, McGowan EM, Parmar I, Jha A, Hubbard BP, Rupasinghe HPV. Kinase-targeted cancer therapies: progress, challenges and future directions. Mol Cancer 2018;17:48. [PMID: 29455673 DOI: 10.1186/s12943-018-0804-2] [Cited by in Crossref: 331] [Cited by in F6Publishing: 283] [Article Influence: 82.8] [Reference Citation Analysis]
52 Klempner SJ, Bubley G. Complementary and alternative medicines in prostate cancer: from bench to bedside? Oncologist 2012;17:830-7. [PMID: 22618569 DOI: 10.1634/theoncologist.2012-0094] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
53 Kim MK, Park GH, Eo HJ, Song HM, Lee JW, Kwon MJ, Koo JS, Jeong JB. Tanshinone I induces cyclin D1 proteasomal degradation in an ERK1/2 dependent way in human colorectal cancer cells. Fitoterapia 2015;101:162-8. [PMID: 25615593 DOI: 10.1016/j.fitote.2015.01.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
54 Tian F, Chen Z, Zhang Y, Jiang J, Li T. Salidroside protects LPS-induced injury in human thyroid follicular epithelial cells by upregulation of MiR-27a. Life Sci 2018;213:1-8. [PMID: 30300656 DOI: 10.1016/j.lfs.2018.10.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
55 Yu M, Epner E. The epigenetics of mantle cell lymphoma. Curr Treat Options Oncol 2007;8:375-81. [PMID: 18214689 DOI: 10.1007/s11864-007-0047-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
56 Banerjee S, Rajamani P. Cellular, Molecular, and Biological Perspective of Polyphenols in Chemoprevention and Therapeutic Adjunct in Cancer. In: Ramawat KG, Mérillon J, editors. Natural Products. Berlin: Springer Berlin Heidelberg; 2013. pp. 2175-254. [DOI: 10.1007/978-3-642-22144-6_72] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
57 Qiao X, Gan M, Wang C, Liu B, Shang Y, Li Y, Chen S. Tetracenomycin X Exerts Antitumour Activity in Lung Cancer Cells through the Downregulation of Cyclin D1. Mar Drugs 2019;17:E63. [PMID: 30669360 DOI: 10.3390/md17010063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
58 Han X, Xu B, Beevers CS, Odaka Y, Chen L, Liu L, Luo Y, Zhou H, Chen W, Shen T, Huang S. Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cells. Carcinogenesis 2012;33:868-75. [PMID: 22298641 DOI: 10.1093/carcin/bgs029] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 5.6] [Reference Citation Analysis]
59 Dorai T, Aggarwal BB. Role of chemopreventive agents in cancer therapy. Cancer Lett. 2004;215:129-140. [PMID: 15488631 DOI: 10.1016/j.canlet.2004.07.013] [Cited by in Crossref: 344] [Cited by in F6Publishing: 303] [Article Influence: 19.1] [Reference Citation Analysis]
60 Swarnalatha Y, Vidhya VG, Murugan A. Isochamanetin is a Selective Inhibitor for CyclinD1 in SKOV3 Cell Lines. Nutr Cancer 2019;71:657-67. [PMID: 30663403 DOI: 10.1080/01635581.2018.1559933] [Reference Citation Analysis]
61 Zendehdel E, Abdollahi E, Momtazi‐borojeni AA, Korani M, Alavizadeh SH, Sahebkar A. The molecular mechanisms of curcumin’s inhibitory effects on cancer stem cells. J Cell Biochem 2019;120:4739-47. [DOI: 10.1002/jcb.27757] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
62 Badr G, Gul HI, Yamali C, Mohamed AA, Badr BM, Gul M, Abo Markeb A, Abo El-maali N. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells. Bioorganic Chemistry 2018;78:46-57. [DOI: 10.1016/j.bioorg.2018.03.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
63 Shishodia S, Aggarwal BB. Nuclear Factor-κB Activation Mediates Cellular Transformation, Proliferation, Invasion Angiogenesis and Metastasis of Cancer. In: Kumar R, editor. Molecular Targeting and Signal Transduction. Boston: Kluwer Academic Publishers; 2004. pp. 139-73. [DOI: 10.1007/1-4020-7847-1_8] [Cited by in Crossref: 88] [Cited by in F6Publishing: 74] [Reference Citation Analysis]
64 Mackenzie GG, Queisser N, Wolfson ML, Fraga CG, Adamo AM, Oteiza PI. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin’s lymphoma cells. Int J Cancer. 2008;123:56-65. [PMID: 18386790 DOI: 10.1002/ijc.23477] [Cited by in Crossref: 106] [Cited by in F6Publishing: 102] [Article Influence: 7.6] [Reference Citation Analysis]
65 Prachayasittikul V, Prathipati P, Pratiwi R, Phanus-Umporn C, Malik AA, Schaduangrat N, Seenprachawong K, Wongchitrat P, Supokawej A, Prachayasittikul V, Wikberg JE, Nantasenamat C. Exploring the epigenetic drug discovery landscape. Expert Opin Drug Discov 2017;12:345-62. [PMID: 28276705 DOI: 10.1080/17460441.2017.1295954] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
66 Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol. 2006;69:195-206. [PMID: 16219905 DOI: 10.1124/mol.105.017400] [Cited by in Crossref: 377] [Cited by in F6Publishing: 351] [Article Influence: 22.2] [Reference Citation Analysis]
67 Ismail NI, Othman I, Abas F, H Lajis N, Naidu R. Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer. Int J Mol Sci 2019;20:E2454. [PMID: 31108984 DOI: 10.3390/ijms20102454] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
68 Rzeski W, Walczak K, Juszczak M, Langner E, Pożarowski P, Kandefer-szerszeń M, Pierzynowski SG. Alpha-ketoglutarate (AKG) inhibits proliferation of colon adenocarcinoma cells in normoxic conditions. Scandinavian Journal of Gastroenterology 2012;47:565-71. [DOI: 10.3109/00365521.2012.660539] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
69 Rodríguez-paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011;17:330-9. [DOI: 10.1038/nm.2305] [Cited by in Crossref: 800] [Cited by in F6Publishing: 730] [Article Influence: 72.7] [Reference Citation Analysis]
70 Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 2011;10:12. [PMID: 21299897 DOI: 10.1186/1476-4598-10-12] [Cited by in Crossref: 548] [Cited by in F6Publishing: 486] [Article Influence: 49.8] [Reference Citation Analysis]
71 Rafiee P, Binion DG, Wellner M, Behmaram B, Floer M, Mitton E, Nie L, Zhang Z, Otterson MF. Modulatory effect of curcumin on survival of irradiated human intestinal microvascular endothelial cells: role of Akt/mTOR and NF-{kappa}B. Am J Physiol Gastrointest Liver Physiol 2010;298:G865-77. [PMID: 20299603 DOI: 10.1152/ajpgi.00339.2009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
72 Teiten MH, Gaascht F, Eifes S, Dicato M, Diederich M. Chemopreventive potential of curcumin in prostate cancer. Genes Nutr 2010;5:61-74. [PMID: 19806380 DOI: 10.1007/s12263-009-0152-3] [Cited by in Crossref: 87] [Cited by in F6Publishing: 85] [Article Influence: 6.7] [Reference Citation Analysis]
73 Somers-Edgar TJ, Scandlyn MJ, Stuart EC, Le Nedelec MJ, Valentine SP, Rosengren RJ. The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivo. Int J Cancer 2008;122:1966-71. [PMID: 18098290 DOI: 10.1002/ijc.23328] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 6.1] [Reference Citation Analysis]
74 Aggarwal B, Kumar A, Aggarwal M, Shishodia S. Curcumin Derived from Turmeric ( Curcuma longa ). In: Bagchi D, Preuss H, editors. Phytopharmaceuticals in Cancer Chemoprevention. CRC Press; 2004. [DOI: 10.1201/9780203506707.ch23] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
75 Mai A, Altucci L. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. Int J Biochem Cell Biol. 2009;41:199-213. [PMID: 18790076 DOI: 10.1016/j.biocel.2008.08.020] [Cited by in Crossref: 138] [Cited by in F6Publishing: 130] [Article Influence: 9.9] [Reference Citation Analysis]
76 Kumaravel M, Sankar P, Latha P, Benson CS, Rukkumani R. Antiproliferative Effects of an Analog of Curcumin in Hep-2 cells: A Comparative Study with Curcumin. Natural Product Communications 2013;8:1934578X1300800. [DOI: 10.1177/1934578x1300800213] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
77 Granata S, Dalla Gassa A, Tomei P, Lupo A, Zaza G. Mitochondria: a new therapeutic target in chronic kidney disease. Nutr Metab (Lond) 2015;12:49. [PMID: 26612997 DOI: 10.1186/s12986-015-0044-z] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
78 Visanji JM, Thompson DG, Padfield PJ. Induction of G2/M phase cell cycle arrest by carnosol and carnosic acid is associated with alteration of cyclin A and cyclin B1 levels. Cancer Lett 2006;237:130-6. [PMID: 16019137 DOI: 10.1016/j.canlet.2005.05.045] [Cited by in Crossref: 89] [Cited by in F6Publishing: 86] [Article Influence: 5.2] [Reference Citation Analysis]
79 Aggarwal BB, Banerjee S, Bharadwaj U, Sung B, Shishodia S, Sethi G. RETRACTED: Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochemical Pharmacology 2007;73:1024-32. [DOI: 10.1016/j.bcp.2006.12.010] [Cited by in Crossref: 109] [Cited by in F6Publishing: 98] [Article Influence: 7.3] [Reference Citation Analysis]
80 Kong Y, Ma W, Liu X, Zu Y, Fu Y, Wu N, Liang L, Yao L, Efferth T. Cytotoxic activity of curcumin towards CCRF-CEM leukemia cells and its effect on DNA damage. Molecules 2009;14:5328-38. [PMID: 20032896 DOI: 10.3390/molecules14125328] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
81 Berrak Ö, Akkoç Y, Arısan ED, Çoker-Gürkan A, Obakan-Yerlikaya P, Palavan-Ünsal N. The inhibition of PI3K and NFκB promoted curcumin-induced cell cycle arrest at G2/M via altering polyamine metabolism in Bcl-2 overexpressing MCF-7 breast cancer cells. Biomed Pharmacother 2016;77:150-60. [PMID: 26796279 DOI: 10.1016/j.biopha.2015.12.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
82 Bagherian A, Roudi B, Masoudian N, Mirzaei H. Anti-glioblastoma effects of nanomicelle-curcumin plus erlotinib. Food Funct 2021;12:10926-37. [PMID: 34647945 DOI: 10.1039/d1fo01611c] [Reference Citation Analysis]
83 Mokgalaboni K, Ntamo Y, Ziqubu K, Nyambuya TM, Nkambule BB, Mazibuko-Mbeje SE, Gabuza KB, Chellan N, Tiano L, Dludla PV. Curcumin supplementation improves biomarkers of oxidative stress and inflammation in conditions of obesity, type 2 diabetes and NAFLD: updating the status of clinical evidence. Food Funct 2021;12:12235-49. [PMID: 34847213 DOI: 10.1039/d1fo02696h] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Heng MC. Curcumin targeted signaling pathways: basis for anti-photoaging and anti-carcinogenic therapy: Curcumin targeted signaling pathways. International Journal of Dermatology 2010;49:608-22. [DOI: 10.1111/j.1365-4632.2010.04468.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
85 Kwak HJ, Park MJ, Park CM, Moon SI, Yoo DH, Lee HC, Lee SH, Kim MS, Lee HW, Shin WS, Park IC, Rhee CH, Hong SI. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation. Int J Cancer. 2006;118:2711-2720. [PMID: 16388516 DOI: 10.1002/ijc.21641] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 4.6] [Reference Citation Analysis]
86 George BP, Chandran R, Abrahamse H. Role of Phytochemicals in Cancer Chemoprevention: Insights. Antioxidants (Basel) 2021;10:1455. [PMID: 34573087 DOI: 10.3390/antiox10091455] [Reference Citation Analysis]
87 Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006;71:1397-1421. [PMID: 16563357 DOI: 10.1016/j.bcp.2006.02.009] [Cited by in Crossref: 1115] [Cited by in F6Publishing: 959] [Article Influence: 69.7] [Reference Citation Analysis]
88 Gandhi AD, Miraclin PA, Abilash D, Sathiyaraj S, Velmurugan R, Zhang Y, Soontarapa K, Sen P, Sridharan TB. Nanosilver reinforced Parmelia sulcata extract efficiently induces apoptosis and inhibits proliferative signalling in MCF-7 cells. Environ Res 2021;199:111375. [PMID: 34048745 DOI: 10.1016/j.envres.2021.111375] [Reference Citation Analysis]
89 Yedjou CG, Mbemi AT, Noubissi F, Tchounwou SS, Tsabang N, Payton M, Miele L, Tchounwou PB. Prostate Cancer Disparity, Chemoprevention, and Treatment by Specific Medicinal Plants. Nutrients 2019;11:E336. [PMID: 30720759 DOI: 10.3390/nu11020336] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
90 Manson MM, Farmer PB, Gescher A, Steward WP. Innovative Agents in Cancer Prevention. In: Senn H, Morant R, editors. Tumor Prevention and Genetics III. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 257-75. [DOI: 10.1007/3-540-26980-0_17] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Reference Citation Analysis]
91 Prakobwong S, Gupta SC, Kim JH, Sung B, Pinlaor P, Hiraku Y, Wongkham S, Sripa B, Pinlaor S, Aggarwal BB. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways. Carcinogenesis 2011;32:1372-80. [PMID: 21325634 DOI: 10.1093/carcin/bgr032] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 8.0] [Reference Citation Analysis]
92 Shehzad A, Wahid F, Lee YS. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim) 2010;343:489-99. [PMID: 20726007 DOI: 10.1002/ardp.200900319] [Cited by in Crossref: 331] [Cited by in F6Publishing: 295] [Article Influence: 27.6] [Reference Citation Analysis]
93 Shehzad A, Shahzad R, Lee YS. Curcumin. Natural Products and Cancer Signaling: Isoprenoids, Polyphenols and Flavonoids. Elsevier; 2014. pp. 149-74. [DOI: 10.1016/b978-0-12-802215-3.00008-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
94 Shirakami Y, Ohnishi M, Sakai H, Tanaka T, Shimizu M. Prevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation. Int J Mol Sci 2017;18:E908. [PMID: 28445390 DOI: 10.3390/ijms18050908] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
95 Banerjee S, Sahoo AK, Chattopadhyay A, Ghosh SS. Chemosensitization of IκBα-overexpressing glioblastoma towards anti-cancer agents. RSC Adv 2014;4:39257-67. [DOI: 10.1039/c4ra03994g] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
96 Miller M, Chen S, Woodliff J, Kansra S. Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells. Endocrinology 2008;149:4158-67. [PMID: 18450960 DOI: 10.1210/en.2007-1760] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
97 Tewari D, Bawari S, Sharma S, DeLiberto LK, Bishayee A. Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: A novel strategy for cancer prevention and therapy. Pharmacol Ther 2021;227:107876. [PMID: 33930452 DOI: 10.1016/j.pharmthera.2021.107876] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
98 Lee SH, Richardson RL, Dashwood RH, Baek SJ. Capsaicin represses transcriptional activity of β-catenin in human colorectal cancer cells. J Nutr Biochem. 2012;23:646-655. [PMID: 21764279 DOI: 10.1016/j.jnutbio.2011.03.009] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
99 Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65:1631-1652. [PMID: 18324353 DOI: 10.1007/s00018-008-7452-4] [Cited by in Crossref: 1080] [Cited by in F6Publishing: 976] [Article Influence: 77.1] [Reference Citation Analysis]
100 Jana NR, Dikshit P, Goswami A, Nukina N. Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J Biol Chem. 2004;279:11680-11685. [PMID: 14701837 DOI: 10.1074/jbc.M310369200] [Cited by in Crossref: 171] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
101 Yamakoshi H, Ohori H, Kudo C, Sato A, Kanoh N, Ishioka C, Shibata H, Iwabuchi Y. Structure-activity relationship of C5-curcuminoids and synthesis of their molecular probes thereof. Bioorg Med Chem 2010;18:1083-92. [PMID: 20060305 DOI: 10.1016/j.bmc.2009.12.045] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
102 Chen M, Yu S. Lipophilic Grape Seed Proanthocyanidin Exerts Anti-Proliferative and Pro-Apoptotic Effects on PC3 Human Prostate Cancer Cells and Suppresses PC3 Xenograft Tumor Growth in Vivo. J Agric Food Chem 2019;67:229-35. [DOI: 10.1021/acs.jafc.8b05936] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
103 Das T, Sa G, Saha B, Das K. Multifocal signal modulation therapy of cancer: ancient weapon, modern targets. Mol Cell Biochem 2010;336:85-95. [DOI: 10.1007/s11010-009-0269-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
104 Thayyullathil F, Chathoth S, Hago A, Patel M, Galadari S. Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase-dependent and -independent apoptosis in L929 cells. Free Radic Biol Med 2008;45:1403-12. [PMID: 18762247 DOI: 10.1016/j.freeradbiomed.2008.08.014] [Cited by in Crossref: 164] [Cited by in F6Publishing: 159] [Article Influence: 11.7] [Reference Citation Analysis]
105 Park GH, Song HM, Jeong JB. The coffee diterpene kahweol suppresses the cell proliferation by inducing cyclin D1 proteasomal degradation via ERK1/2, JNK and GKS3β-dependent threonine-286 phosphorylation in human colorectal cancer cells. Food Chem Toxicol 2016;95:142-8. [PMID: 27424123 DOI: 10.1016/j.fct.2016.07.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
106 Wang SJ, Gao Y, Chen H, Kong R, Jiang HC, Pan SH, Xue DB, Bai XW, Sun B. Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer Lett. 2010;293:99-108. [PMID: 20137856 DOI: 10.1016/j.canlet.2010.01.001] [Cited by in Crossref: 108] [Cited by in F6Publishing: 107] [Article Influence: 9.0] [Reference Citation Analysis]
107 Shishodia S, Chaturvedi MM, Aggarwal BB. Role of Curcumin in Cancer Therapy. Current Problems in Cancer 2007;31:243-305. [DOI: 10.1016/j.currproblcancer.2007.04.001] [Cited by in Crossref: 286] [Cited by in F6Publishing: 265] [Article Influence: 19.1] [Reference Citation Analysis]
108 Bandyopadhyaya G, Sinha S, Chattopadhyay BD, Chakraborty A. Protective role of curcumin against nicotine-induced genotoxicity on rat liver under restricted dietary protein. European Journal of Pharmacology 2008;588:151-7. [DOI: 10.1016/j.ejphar.2008.04.023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
109 Bimonte S, Barbieri A, Palma G, Luciano A, Rea D, Arra C. Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer. Biomed Res Int. 2013;2013:810423. [PMID: 24324975 DOI: 10.1155/2013/810423] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
110 Eckert RL, Crish JF, Efimova T, Balasubramanian S. Antioxidants regulate normal human keratinocyte differentiation. Biochem Pharmacol 2004;68:1125-31. [PMID: 15313409 DOI: 10.1016/j.bcp.2004.04.029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
111 Jeong JB, Lee SH. Protocatechualdehyde possesses anti-cancer activity through downregulating cyclin D1 and HDAC2 in human colorectal cancer cells. Biochem Biophys Res Commun 2013;430:381-6. [PMID: 23159608 DOI: 10.1016/j.bbrc.2012.11.018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
112 Zhang Y, Lin XY, Zhang JH, Xie ZL, Deng H, Huang YF, Huang XH. Apoptosis of mouse myeloma cells induced by curcumin via the Notch3-p53 signaling axis. Oncol Lett 2019;17:127-34. [PMID: 30655747 DOI: 10.3892/ol.2018.9591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Miller S, Stagl J, Wallerstedt DB, Ryan M, Mansky PJ. Botanicals used in complementary and alternative medicine treatment of cancer: clinical science and future perspectives. Expert Opinion on Investigational Drugs 2008;17:1353-64. [DOI: 10.1517/13543784.17.9.1353] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
114 Rahmani AH, Al Zohairy MA, Aly SM, Khan MA. Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways. Biomed Res Int. 2014;2014:761608. [PMID: 25295272 DOI: 10.1155/2014/761608] [Cited by in Crossref: 104] [Cited by in F6Publishing: 83] [Article Influence: 13.0] [Reference Citation Analysis]
115 da Silva D, Magalhães T, dos Santos J, de Paula T, Modolo L, de Fátima A, Buzanello Martins C, Santos D, de Resende-stoianoff M. Curcumin enhances the activity of fluconazole against Cryptococcus gattii -induced cryptococcosis infection in mice. J Appl Microbiol 2016;120:41-8. [DOI: 10.1111/jam.12966] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
116 Tapia R, Huerta M, Islas S, Avila-Flores A, Lopez-Bayghen E, Weiske J, Huber O, González-Mariscal L. Zona occludens-2 inhibits cyclin D1 expression and cell proliferation and exhibits changes in localization along the cell cycle. Mol Biol Cell 2009;20:1102-17. [PMID: 19056685 DOI: 10.1091/mbc.e08-03-0277] [Cited by in Crossref: 60] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
117 Tsvetkov P, Asher G, Reiss V, Shaul Y, Sachs L, Lotem J. Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci U S A 2005;102:5535-40. [PMID: 15809436 DOI: 10.1073/pnas.0501828102] [Cited by in Crossref: 107] [Cited by in F6Publishing: 109] [Article Influence: 6.3] [Reference Citation Analysis]
118 Chandrasekaran PR, Madanagopalan VG. Role of Curcumin in Retinal Diseases-A review. Graefes Arch Clin Exp Ophthalmol 2022. [PMID: 35015114 DOI: 10.1007/s00417-021-05542-0] [Reference Citation Analysis]
119 Hung CT, Huang SM, Cheng HC, Liu ST, Chang YL, Liu YC, Wang WM. The inhibitory mechanism by curcumin on the Zac1-enhanced cyclin D1 expression in human keratinocytes. J Dermatol Sci 2015;79:262-7. [PMID: 26094054 DOI: 10.1016/j.jdermsci.2015.06.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
120 Takahashi-Yanaga F, Sasaguri T. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy. Cell Signal 2008;20:581-9. [PMID: 18023328 DOI: 10.1016/j.cellsig.2007.10.018] [Cited by in Crossref: 180] [Cited by in F6Publishing: 179] [Article Influence: 12.0] [Reference Citation Analysis]
121 Song S, Krishnan K, Liu K, Bresalier RS. Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression. Clin Cancer Res. 2009;15:622-631. [PMID: 19147768 DOI: 10.1158/1078-0432.ccr-08-0772] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
122 Rowe DL, Ozbay T, O'Regan RM, Nahta R. Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin. Breast Cancer (Auckl) 2009;3:61-75. [PMID: 19809577 DOI: 10.4137/bcbcr.s3067] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
123 Bi Y, Fu Y, Wang S, Chen X, Cai X. Schizandrin A exerts anti-tumor effects on A375 cells by down-regulating H19. Braz J Med Biol Res 2019;52:e8385. [PMID: 31618367 DOI: 10.1590/1414-431X20198385] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
124 Ramos-garcía P, Gil-montoya J, Scully C, Ayén A, González-ruiz L, Navarro-triviño F, González-moles M. An update on the implications of cyclin D1 in oral carcinogenesis. Oral Dis 2017;23:897-912. [DOI: 10.1111/odi.12620] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 9.2] [Reference Citation Analysis]
125 Garige M, Walters E. Curcumin inhibits development and cell adhesion in Dictyostelium discoideum: Implications for YakA signaling and GST enzyme function. Biochem Biophys Res Commun 2015;467:275-81. [PMID: 26449461 DOI: 10.1016/j.bbrc.2015.09.175] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
126 Shirakami Y, Shimizu M, Kubota M, Araki H, Tanaka T, Moriwaki H, Seishima M. Chemoprevention of colorectal cancer by targeting obesity-related metabolic abnormalities. World J Gastroenterol 2014; 20(27): 8939-8946 [PMID: 25083066 DOI: 10.3748/wjg.v20.i27.8939] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
127 Xiao Y, Xu C, Xiong H, Du S, Zhou J, Yin L, Yao J. Dose-reduction antiangiogenic curcumin-low molecular weight heparin nanodrugs for enhanced combinational antitumor therapy. European Journal of Pharmaceutical Sciences 2018;119:121-34. [DOI: 10.1016/j.ejps.2018.04.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
128 Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, Kondo Y. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol. 2007;72:29-39. [PMID: 17395690 DOI: 10.1124/mol.106.033167] [Cited by in Crossref: 352] [Cited by in F6Publishing: 344] [Article Influence: 23.5] [Reference Citation Analysis]
129 Ye M, Xu M, Ding M, Ji C, Ji J, Ji F, Wei W, Yang S, Zhou B. Gender associated effects of the ethanolic extracts of Chinese propolis on the hepatic transcriptome in ethanol-treated mice. Iran J Basic Med Sci 2019;22:1211-7. [PMID: 31998465 DOI: 10.22038/ijbms.2019.37348.8886] [Reference Citation Analysis]
130 Kizhakkayil J, Thayyullathil F, Chathoth S, Hago A, Patel M, Galadari S. Modulation of curcumin-induced Akt phosphorylation and apoptosis by PI3K inhibitor in MCF-7 cells. Biochem Biophys Res Commun 2010;394:476-81. [PMID: 20138829 DOI: 10.1016/j.bbrc.2010.01.132] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
131 Teiten MH, Eifes S, Dicato M, Diederich M. Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins (Basel) 2010;2:128-62. [PMID: 22069551 DOI: 10.3390/toxins2010128] [Cited by in Crossref: 134] [Cited by in F6Publishing: 116] [Article Influence: 11.2] [Reference Citation Analysis]
132 Watanabe M, Iizumi Y, Sukeno M, Iizuka-Ohashi M, Sowa Y, Sakai T. The pleiotropic regulation of cyclin D1 by newly identified sesaminol-binding protein ANT2. Oncogenesis 2017;6:e311. [PMID: 28368390 DOI: 10.1038/oncsis.2017.10] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
133 Wang L, Sun Y, Huang K, Zheng L. Curcumin, a potential therapeutic candidate for retinal diseases. Mol Nutr Food Res 2013;57:1557-68. [DOI: 10.1002/mnfr.201200718] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
134 Sethi G, Sung B, Aggarwal BB. The Role of Curcumin in Modern Medicine. In: Ramawat K, editor. Herbal Drugs: Ethnomedicine to Modern Medicine. Berlin: Springer Berlin Heidelberg; 2009. pp. 97-113. [DOI: 10.1007/978-3-540-79116-4_7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
135 Akkoç Y, Berrak Ö, Arısan ED, Obakan P, Çoker-gürkan A, Palavan-ünsal N. Inhibition of PI3K signaling triggered apoptotic potential of curcumin which is hindered by Bcl-2 through activation of autophagy in MCF-7 cells. Biomedicine & Pharmacotherapy 2015;71:161-71. [DOI: 10.1016/j.biopha.2015.02.029] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
136 Mathew D, Hsu W. Antiviral potential of curcumin. Journal of Functional Foods 2018;40:692-9. [DOI: 10.1016/j.jff.2017.12.017] [Cited by in Crossref: 80] [Cited by in F6Publishing: 43] [Article Influence: 20.0] [Reference Citation Analysis]
137 Nocito MC, De Luca A, Prestia F, Avena P, La Padula D, Zavaglia L, Sirianni R, Casaburi I, Puoci F, Chimento A, Pezzi V. Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability. Biomedicines 2021;9:1476. [PMID: 34680593 DOI: 10.3390/biomedicines9101476] [Reference Citation Analysis]
138 Cheng YH, Li LA, Lin P, Cheng LC, Hung CH, Chang NW, Lin C. Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation. Toxicol Appl Pharmacol 2012;263:360-7. [PMID: 22820424 DOI: 10.1016/j.taap.2012.07.010] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
139 Wei S, Yang HC, Chuang HC, Yang J, Kulp SK, Lu PJ, Lai MD, Chen CS. A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells. J Biol Chem 2008;283:26759-70. [PMID: 18650423 DOI: 10.1074/jbc.M802160200] [Cited by in Crossref: 56] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
140 Yan G, Graham K, Lanza-Jacoby S. Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells. Mol Carcinog 2013;52:404-11. [PMID: 22290509 DOI: 10.1002/mc.21875] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
141 Masamune A, Suzuki N, Kikuta K, Satoh M, Satoh K, Shimosegawa T. Curcumin blocks activation of pancreatic stellate cells. J Cell Biochem 2006;97:1080-93. [PMID: 16294327 DOI: 10.1002/jcb.20698] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 3.7] [Reference Citation Analysis]
142 Zheng S, Chen A. Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro. Biochem J. 2004;384:149-157. [PMID: 15320868 DOI: 10.1042/bj20040928] [Cited by in Crossref: 88] [Cited by in F6Publishing: 54] [Article Influence: 5.2] [Reference Citation Analysis]
143 Zong H, Wang F, Fan QX, Wang LX. Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways. Mol Biol Rep. 2012;39:4803-4808. [PMID: 21947854 DOI: 10.1007/s11033-011-1273-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
144 Yang WE, Ho YC, Tang CM, Hsieh YS, Chen PN, Lai CT, Yang SF, Lin CW. Duchesnea indica extract attenuates oral cancer cells metastatic potential through the inhibition of the matrix metalloproteinase-2 activity by down-regulating the MEK/ERK pathway. Phytomedicine 2019;63:152960. [PMID: 31280137 DOI: 10.1016/j.phymed.2019.152960] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
145 Kurien BT, Harris VM, Quadri SM, Coutinho-de Souza P, Cavett J, Moyer A, Ittiq B, Metcalf A, Ramji HF, Truong D, Kumar R, Koelsch KA, Centola M, Payne A, Danda D, Scofield RH. Significantly reduced lymphadenopathy, salivary gland infiltrates and proteinuria in MRL-lpr/lpr mice treated with ultrasoluble curcumin/turmeric: increased survival with curcumin treatment. Lupus Sci Med 2015;2:e000114. [PMID: 26380101 DOI: 10.1136/lupus-2015-000114] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
146 Yan WJ, Ma XC, Gao XY, Xue XH, Zhang SQ. Latest research progress in the correlation between baicalein and breast cancer invasion and metastasis. Mol Clin Oncol 2016;4:472-6. [PMID: 27073644 DOI: 10.3892/mco.2016.750] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
147 Ghasemi F, Shafiee M, Banikazemi Z, Pourhanifeh MH, Khanbabaei H, Shamshirian A, Amiri Moghadam S, ArefNezhad R, Sahebkar A, Avan A, Mirzaei H. Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells. Pathol Res Pract 2019;215:152556. [PMID: 31358480 DOI: 10.1016/j.prp.2019.152556] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 22.7] [Reference Citation Analysis]
148 Viennois E, Chen F, Merlin D. NF-κB pathway in colitis-associated cancers. Transl Gastrointest Cancer 2013;2:21-9. [PMID: 23626930 DOI: 10.3978/j.issn.2224-4778.2012.11.01] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
149 Yoysungnoen P, Wirachwong P, Changtam C, Suksamrarn A, Patumraj S. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World J Gastroenterol 2008; 14(13): 2003-2009 [PMID: 18395899 DOI: 10.3748/wjg.14.2003] [Cited by in CrossRef: 94] [Cited by in F6Publishing: 81] [Article Influence: 6.7] [Reference Citation Analysis]
150 Aggarwal BB, Shishodia S. Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci. 2004;1030:434-441. [PMID: 15659827 DOI: 10.1196/annals.1329.054] [Cited by in Crossref: 220] [Cited by in F6Publishing: 173] [Article Influence: 12.9] [Reference Citation Analysis]
151 Neff BA, Oberstien E, Lorenz M, Chaudhury AR, Welling DB, Chang L. Cyclin D1 and D3 Expression in Vestibular Schwannomas: . The Laryngoscope 2006;116:423-6. [DOI: 10.1097/01.mlg.0000195076.05466.6c] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
152 Rainey NE, Moustapha A, Petit PX. Curcumin, a Multifaceted Hormetic Agent, Mediates an Intricate Crosstalk between Mitochondrial Turnover, Autophagy, and Apoptosis. Oxid Med Cell Longev 2020;2020:3656419. [PMID: 32765806 DOI: 10.1155/2020/3656419] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
153 Allam G. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni. Immunobiology 2009;214:712-27. [PMID: 19249123 DOI: 10.1016/j.imbio.2008.11.017] [Cited by in Crossref: 91] [Cited by in F6Publishing: 80] [Article Influence: 7.0] [Reference Citation Analysis]
154 Eo HJ, Park GH, Song HM, Lee JW, Kim MK, Lee MH, Lee JR, Koo JS, Jeong JB. Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in human colorectal cancer cells. International Immunopharmacology 2015;24:1-6. [DOI: 10.1016/j.intimp.2014.11.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
155 HemaIswarya S, Doble M. Potential synergism of natural products in the treatment of cancer. Phytother Res. 2006;20:239-249. [PMID: 16557604 DOI: 10.1002/ptr.1841] [Cited by in Crossref: 137] [Cited by in F6Publishing: 133] [Article Influence: 8.6] [Reference Citation Analysis]
156 Chen A, Xu J. Activation of PPARγ by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. American Journal of Physiology-Gastrointestinal and Liver Physiology 2005;288:G447-56. [DOI: 10.1152/ajpgi.00209.2004] [Cited by in Crossref: 92] [Cited by in F6Publishing: 94] [Article Influence: 5.4] [Reference Citation Analysis]
157 Calaf GM. Curcumin, Oxidative Stress, and Breast Cancer. Cancer. Elsevier; 2014. pp. 159-69. [DOI: 10.1016/b978-0-12-405205-5.00015-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
158 Yadav VS, Mishra KP, Singh DP, Mehrotra S, Singh VK. Immunomodulatory effects of curcumin. Immunopharmacol Immunotoxicol. 2005;27:485-497. [PMID: 16237958 DOI: 10.1080/08923970500242244] [Cited by in Crossref: 99] [Cited by in F6Publishing: 92] [Article Influence: 5.8] [Reference Citation Analysis]
159 Yang CL, Liu YY, Ma YG, Xue YX, Liu DG, Ren Y, Liu XB, Li Y, Li Z. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One. 2012;7:e37960. [PMID: 22662257 DOI: 10.1371/journal.pone.0037960] [Cited by in Crossref: 134] [Cited by in F6Publishing: 127] [Article Influence: 13.4] [Reference Citation Analysis]
160 Shimizu M, Weinstein IB. Modulation of signal transduction by tea catechins and related phytochemicals. Mutat Res. 2005;591:147-160. [PMID: 15992833 DOI: 10.1016/j.mrfmmm.2005.04.010] [Cited by in Crossref: 91] [Cited by in F6Publishing: 78] [Article Influence: 5.4] [Reference Citation Analysis]
161 Klinger NV, Mittal S. Anticancer Properties of Curcumin and Its Efficacy for Treating Central Nervous System Neoplasms. In: Akhtar MS, Swamy MK, editors. Anticancer plants: Properties and Application. Singapore: Springer; 2018. pp. 349-66. [DOI: 10.1007/978-981-10-8548-2_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
162 Shishodia S, Koul D, Aggarwal BB. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. J Immunol 2004;173:2011-22. [PMID: 15265936 DOI: 10.4049/jimmunol.173.3.2011] [Cited by in Crossref: 144] [Cited by in F6Publishing: 131] [Article Influence: 8.0] [Reference Citation Analysis]
163 Dong S, Alahari SK. Combination treatment of bicalutamide and curcumin has a strong therapeutic effect on androgen receptor-positive triple-negative breast cancers. Anticancer Drugs 2020;31:359-67. [PMID: 31917699 DOI: 10.1097/CAD.0000000000000880] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 León D, Uribe E, Zambrano A, Salas M. Implications of Resveratrol on Glucose Uptake and Metabolism. Molecules 2017;22:E398. [PMID: 28272357 DOI: 10.3390/molecules22030398] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
165 Shemesh N, Arber N. Curcumin Alone and in Combination for Prevention of Colorectal Cancer. Curr Colorectal Cancer Rep 2014;10:62-7. [DOI: 10.1007/s11888-013-0207-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
166 Nagai S, Kurimoto M, Washiyama K, Hirashima Y, Kumanishi T, Endo S. Inhibition of Cellular Proliferation and Induction of Apoptosis by Curcumin in Human Malignant Astrocytoma Cell Lines. J Neurooncol 2005;74:105-11. [DOI: 10.1007/s11060-004-5757-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
167 Hua WF, Fu YS, Liao YJ, Xia WJ, Chen YC, Zeng YX, Kung HF, Xie D. Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells. Eur J Pharmacol 2010;637:16-21. [PMID: 20385124 DOI: 10.1016/j.ejphar.2010.03.051] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 5.3] [Reference Citation Analysis]
168 Cabrespine-faugeras A, Bayet-robert M, Bay J, Chollet P, Barthomeuf C. Possible Benefits of Curcumin Regimen in Combination With Taxane Chemotherapy for Hormone-Refractory Prostate Cancer Treatment. Nutrition and Cancer 2010;62:148-53. [DOI: 10.1080/01635580903305383] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
169 Lee SH, Cekanova M, Baek SJ. Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog 2008;47:197-208. [PMID: 18058799 DOI: 10.1002/mc.20374] [Cited by in Crossref: 127] [Cited by in F6Publishing: 110] [Article Influence: 9.1] [Reference Citation Analysis]
170 Aggarwal BB, Sundaram C, Malani N, Ichikawa H. CURCUMIN: THE INDIAN SOLID GOLD. In: Aggarwal BB, Surh Y, Shishodia S, editors. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. Boston: Springer US; 2007. pp. 1-75. [DOI: 10.1007/978-0-387-46401-5_1] [Cited by in Crossref: 817] [Cited by in F6Publishing: 716] [Reference Citation Analysis]
171 Eo HJ, Park GH, Jeong JB. The involvement of cyclin D1 degradation through GSK3β-mediated threonine-286 phosphorylation-dependent nuclear export in anti-cancer activity of mulberry root bark extracts. Phytomedicine 2016;23:105-13. [PMID: 26926171 DOI: 10.1016/j.phymed.2015.12.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
172 Shao W, Yu Z, Chiang Y, Yang Y, Chai T, Foltz W, Lu H, Fantus IG, Jin T. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS One. 2012;7:e28784. [PMID: 22253696 DOI: 10.1371/journal.pone.0028784] [Cited by in Crossref: 157] [Cited by in F6Publishing: 144] [Article Influence: 15.7] [Reference Citation Analysis]
173 Hesari A, Rezaei M, Rezaei M, Dashtiahangar M, Fathi M, Rad JG, Momeni F, Avan A, Ghasemi F. Effect of curcumin on glioblastoma cells. J Cell Physiol 2019;234:10281-8. [DOI: 10.1002/jcp.27933] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
174 Lim TG, Lee SY, Huang Z, Lim do Y, Chen H, Jung SK, Bode AM, Lee KW, Dong Z. Curcumin suppresses proliferation of colon cancer cells by targeting CDK2. Cancer Prev Res (Phila). 2014;7:466-474. [PMID: 24550143 DOI: 10.1158/1940-6207.CAPR-13-0387] [Cited by in Crossref: 60] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
175 Kizhakkayil J, Thayyullathil F, Chathoth S, Hago A, Patel M, Galadari S. Glutathione regulates caspase-dependent ceramide production and curcumin-induced apoptosis in human leukemic cells. Free Radic Biol Med 2012;52:1854-64. [PMID: 22387197 DOI: 10.1016/j.freeradbiomed.2012.02.026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
176 Shanmugam MK, Rane G, Kanchi MM, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Tan BK, Kumar AP, Sethi G. The multifaceted role of curcumin in cancer prevention and treatment. Molecules 2015;20:2728-69. [PMID: 25665066 DOI: 10.3390/molecules20022728] [Cited by in Crossref: 228] [Cited by in F6Publishing: 205] [Article Influence: 32.6] [Reference Citation Analysis]
177 Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D, Chen YC, Honoki K, Fujii H, Georgakilas AG, Nowsheen S, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich B, Yang X, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Halicka D, Mohammed SI, Azmi AS, Bilsland A, Keith WN, Jensen LD. Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol 2015;35 Suppl:S224-43. [PMID: 25600295 DOI: 10.1016/j.semcancer.2015.01.001] [Cited by in Crossref: 245] [Cited by in F6Publishing: 225] [Article Influence: 35.0] [Reference Citation Analysis]
178 Sa G, Das T. Anti cancer effects of curcumin: cycle of life and death. Cell Div 2008;3:14. [PMID: 18834508 DOI: 10.1186/1747-1028-3-14] [Cited by in Crossref: 210] [Cited by in F6Publishing: 189] [Article Influence: 15.0] [Reference Citation Analysis]
179 Chen KL, Jung P, Kulkoyluoglu-Cotul E, Liguori C, Lumibao J, Mazewski C, Ranard K, Rowles JL 3rd, Wang Y, Xue L, Madak-Erdogan Z. Impact of Diet and Nutrition on Cancer Hallmarks. J Cancer Prev Curr Res 2017;7:240. [PMID: 30581989 DOI: 10.15406/jcpcr.2017.07.00240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
180 Iqbal B, Ghildiyal A, Sahabjada, Singh S, Arshad M, Mahdi AA, Tiwari S. Antiproliferative and Apoptotic Effect of Curcumin and TRAIL (TNF Related Apoptosis inducing Ligand) in Chronic Myeloid Leukaemic Cells. J Clin Diagn Res 2016;10:XC01-5. [PMID: 27190933 DOI: 10.7860/JCDR/2016/18507.7579] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
181 Eckert RL, Crish JF, Efimova T, Balasubramanian S. Opposing action of curcumin and green tea polyphenol in human keratinocytes. Mol Nutr Food Res 2006;50:123-9. [PMID: 16404707 DOI: 10.1002/mnfr.200500125] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
182 Agame-Lagunes B, Alegria-Rivadeneyra M, Quintana-Castro R, Torres-Palacios C, Grube-Pagola P, Cano-Sarmiento C, Garcia-Varela R, Alexander-Aguilera A, García HS. Curcumin Nanoemulsions Stabilized with Modified Phosphatidylcholine on Skin Carcinogenesis Protocol. Curr Drug Metab 2020;21:226-34. [PMID: 32348213 DOI: 10.2174/1389200221666200429111928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Pari L, Tewas D, Eckel J. Role of curcumin in health and disease. Archives of Physiology and Biochemistry 2008;114:127-49. [DOI: 10.1080/13813450802033958] [Cited by in Crossref: 134] [Cited by in F6Publishing: 112] [Article Influence: 9.6] [Reference Citation Analysis]
184 Vyas D, Gupt S, Dixit V, Anita K, Kaur S. To study the effect of curcumin on the growth properties of circulating endothelial progenitor cells. In Vitro Cell Dev Biol Anim 2015;51:488-94. [PMID: 25583641 DOI: 10.1007/s11626-014-9852-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
185 Manson MM. Inhibition of survival signalling by dietary polyphenols and indole-3-carbinol. Eur J Cancer. 2005;41:1842-1853. [PMID: 16087329 DOI: 10.1016/j.ejca.2005.05.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
186 Shahani K, Swaminathan SK, Freeman D, Blum A, Ma L, Panyam J. Injectable sustained release microparticles of curcumin: a new concept for cancer chemoprevention. Cancer Res 2010;70:4443-52. [PMID: 20460537 DOI: 10.1158/0008-5472.CAN-09-4362] [Cited by in Crossref: 84] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
187 Perabo FG, von Löw EC, Siener R, Ellinger J, Müller SC, Bastian PJ. [A critical assessment of phytotherapy for prostate cancer]. Urologe A 2009;48:270-1, 274-83. [PMID: 19153707 DOI: 10.1007/s00120-008-1929-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
188 Elkady AI, Abuzinadah OA, Baeshen NA, Rahmy TR. Differential control of growth, apoptotic activity, and gene expression in human breast cancer cells by extracts derived from medicinal herbs Zingiber officinale. J Biomed Biotechnol. 2012;2012:614356. [PMID: 22969274 DOI: 10.1155/2012/614356] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
189 Martin RC, Aiyer HS, Malik D, Li Y. Effect on pro-inflammatory and antioxidant genes and bioavailable distribution of whole turmeric vs curcumin: Similar root but different effects. Food Chem Toxicol 2012;50:227-31. [PMID: 22079310 DOI: 10.1016/j.fct.2011.10.070] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
190 Sung B, Prasad S, Gupta SC, Patchva S, Aggarwal BB. Regulation of Inflammation-Mediated Chronic Diseases by Botanicals. Recent Trends in Medicinal Plants Research. Elsevier; 2012. pp. 57-132. [DOI: 10.1016/b978-0-12-394591-4.00003-9] [Cited by in Crossref: 10] [Article Influence: 1.0] [Reference Citation Analysis]
191 López-Lázaro M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol Nutr Food Res 2008;52 Suppl 1:S103-27. [PMID: 18496811 DOI: 10.1002/mnfr.200700238] [Cited by in Crossref: 46] [Cited by in F6Publishing: 111] [Article Influence: 3.3] [Reference Citation Analysis]
192 Hou Y, Liu R, Xia M, Sun C, Zhong B, Yu J, Ai N, Lu JJ, Ge W, Liu B, Chen X. Nannocystin ax, an eEF1A inhibitor, induces G1 cell cycle arrest and caspase-independent apoptosis through cyclin D1 downregulation in colon cancer in vivo. Pharmacol Res 2021;173:105870. [PMID: 34500061 DOI: 10.1016/j.phrs.2021.105870] [Reference Citation Analysis]
193 Zoi V, Galani V, Vartholomatos E, Zacharopoulou N, Tsoumeleka E, Gkizas G, Bozios G, Tsekeris P, Chousidis I, Leonardos I, Tzakos AG, Kyritsis AP, Alexiou GA. Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro. Biomedicines 2021;9:1562. [PMID: 34829791 DOI: 10.3390/biomedicines9111562] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Sethi G, Sung B, Aggarwal BB. Nuclear factor-kappaB activation: from bench to bedside. Exp Biol Med (Maywood). 2008;233:21-31. [PMID: 18156302 DOI: 10.3181/0707-mr-196] [Cited by in Crossref: 301] [Cited by in F6Publishing: 140] [Article Influence: 21.5] [Reference Citation Analysis]
195 Zhu G, Liu X, Li H, Yan Y, Hong X, Lin Z. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21. Int J Immunopathol Pharmacol 2018;32:2058738418814341. [PMID: 30477356 DOI: 10.1177/2058738418814341] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
196 Hasanali Z, Sharma K, Epner E. Flipping the cyclin D1 switch in mantle cell lymphoma. Best Pract Res Clin Haematol 2012;25:143-52. [PMID: 22687450 DOI: 10.1016/j.beha.2012.03.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
197 Xu W, Du M, Zhao Y, Wang Q, Sun W, Chen B. γ-Tocotrienol inhibits cell viability through suppression of β-catenin/Tcf signaling in human colon carcinoma HT-29 cells. The Journal of Nutritional Biochemistry 2012;23:800-7. [DOI: 10.1016/j.jnutbio.2011.04.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
198 Choi J, Jiang X, Jeong JB, Lee SH. Anticancer activity of protocatechualdehyde in human breast cancer cells. J Med Food 2014;17:842-8. [PMID: 24712725 DOI: 10.1089/jmf.2013.0159] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
199 Ki HH, Poudel B, Lee JH, Lee YM, Kim DK. In vitro and in vivo anti-cancer activity of dichloromethane fraction of Triticum aestivum sprouts. Biomed Pharmacother 2017;96:120-8. [PMID: 28972884 DOI: 10.1016/j.biopha.2017.09.118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
200 Murray TJ, Yang X, Sherr DH. Growth of a human mammary tumor cell line is blocked by galangin, a naturally occurring bioflavonoid, and is accompanied by down-regulation of cyclins D3, E, and A. Breast Cancer Res 2006;8:R17. [PMID: 16569260 DOI: 10.1186/bcr1391] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 3.0] [Reference Citation Analysis]
201 Vecchi Brumatti L, Marcuzzi A, Tricarico PM, Zanin V, Girardelli M, Bianco AM. Curcumin and inflammatory bowel disease: potential and limits of innovative treatments. Molecules. 2014;19:21127-21153. [PMID: 25521115 DOI: 10.3390/molecules191221127] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 8.8] [Reference Citation Analysis]
202 Harsono D, Finelt N, Castano EB, Tonnesen MG, Clark RAF. Curcumin myths or wonders? A systematic analysis of in vitro studies. Wound Repair Regen 2013;21:335-6. [DOI: 10.1111/wrr.12019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
203 Chakravarti N, Myers JN, Aggarwal BB. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Int J Cancer 2006;119:1268-75. [PMID: 16642480 DOI: 10.1002/ijc.21967] [Cited by in Crossref: 82] [Cited by in F6Publishing: 82] [Article Influence: 5.1] [Reference Citation Analysis]
204 Nurtjahja-Tjendraputra E, Fu D, Phang JM, Richardson DR. Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression. Blood 2007;109:4045-54. [PMID: 17197429 DOI: 10.1182/blood-2006-10-047753] [Cited by in Crossref: 103] [Cited by in F6Publishing: 98] [Article Influence: 6.4] [Reference Citation Analysis]
205 Zhu M, Zheng Z, Huang J, Ma X, Huang C, Wu R, Li X, Liang Z, Deng F, Wu J, Geng S, Xie C, Zhong C. Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells. J Cell Biochem 2019;120:15616-24. [PMID: 31042325 DOI: 10.1002/jcb.28828] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
206 Yokota T, Matsuzaki Y, Koyama M, Hitomi T, Kawanaka M, Enoki-Konishi M, Okuyama Y, Takayasu J, Nishino H, Nishikawa A, Osawa T, Sakai T. Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells. Cancer Sci 2007;98:1447-53. [PMID: 17640297 DOI: 10.1111/j.1349-7006.2007.00560.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 58] [Article Influence: 5.0] [Reference Citation Analysis]
207 Shishodia S. Molecular mechanisms of curcumin action: gene expression. Biofactors 2013;39:37-55. [PMID: 22996381 DOI: 10.1002/biof.1041] [Cited by in Crossref: 136] [Cited by in F6Publishing: 122] [Article Influence: 13.6] [Reference Citation Analysis]
208 Liang HH, Wei PL, Hung CS, Wu CT, Wang W, Huang MT, Chang YJ. MicroRNA-200a/b influenced the therapeutic effects of curcumin in hepatocellular carcinoma (HCC) cells. Tumour Biol 2013;34:3209-18. [PMID: 23760980 DOI: 10.1007/s13277-013-0891-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
209 Horie S. Chemoprevention of prostate cancer: soy isoflavones and curcumin. Korean J Urol 2012;53:665-72. [PMID: 23136625 DOI: 10.4111/kju.2012.53.10.665] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
210 Barranco WT, Eckhert CD. Cellular changes in boric acid-treated DU-145 prostate cancer cells. Br J Cancer 2006;94:884-90. [PMID: 16495920 DOI: 10.1038/sj.bjc.6603009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
211 Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, Bhatt ID, Pandey MK, Shishodia S, Nair MG. From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opinion on Therapeutic Targets 2006;10:87-118. [DOI: 10.1517/14728222.10.1.87] [Cited by in Crossref: 161] [Cited by in F6Publishing: 128] [Article Influence: 10.1] [Reference Citation Analysis]
212 Song HM, Park GH, Eo HJ, Lee JW, Kim MK, Lee JR, Lee MH, Koo JS, Jeong JB. Anti-Proliferative Effect of Naringenin through p38-Dependent Downregulation of Cyclin D1 in Human Colorectal Cancer Cells. Biomol Ther (Seoul) 2015;23:339-44. [PMID: 26157550 DOI: 10.4062/biomolther.2015.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
213 Simion V, Stan D, Constantinescu CA, Deleanu M, Dragan E, Tucureanu MM, Gan AM, Butoi E, Constantin A, Manduteanu I, Simionescu M, Calin M. Conjugation of curcumin-loaded lipid nanoemulsions with cell-penetrating peptides increases their cellular uptake and enhances the anti-inflammatory effects in endothelial cells. J Pharm Pharmacol 2016;68:195-207. [PMID: 26748549 DOI: 10.1111/jphp.12513] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
214 Shehzad A, Wahid F, Lee YS. Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials. Arch Pharm Pharm Med Chem 2010;343:489-99. [DOI: 10.1002/ardp.200900319] [Reference Citation Analysis]
215 Jin Y, Dai Z. USO1 promotes tumor progression via activating Erk pathway in multiple myeloma cells. Biomedicine & Pharmacotherapy 2016;78:264-71. [DOI: 10.1016/j.biopha.2016.01.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
216 Termini D, Den Hartogh DJ, Jaglanian A, Tsiani E. Curcumin against Prostate Cancer: Current Evidence. Biomolecules 2020;10:E1536. [PMID: 33182828 DOI: 10.3390/biom10111536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
217 Choi HK, Ryu H, Son AR, Seo B, Hwang SG, Song JY, Ahn J. The novel anthraquinone derivative IMP1338 induces death of human cancer cells by p53-independent S and G2/M cell cycle arrest. Biomed Pharmacother 2016;79:308-14. [PMID: 27044842 DOI: 10.1016/j.biopha.2016.02.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
218 Balasubramanian S, Eckert RL. Curcumin suppresses AP1 transcription factor-dependent differentiation and activates apoptosis in human epidermal keratinocytes. J Biol Chem 2007;282:6707-15. [PMID: 17148446 DOI: 10.1074/jbc.M606003200] [Cited by in Crossref: 66] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
219 Prasad CP, Rath G, Mathur S, Bhatnagar D, Ralhan R. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/β-catenin signaling. Chemico-Biological Interactions 2009;181:263-71. [DOI: 10.1016/j.cbi.2009.06.012] [Cited by in Crossref: 101] [Cited by in F6Publishing: 89] [Article Influence: 7.8] [Reference Citation Analysis]
220 Charpentier MS, Whipple RA, Vitolo MI, Boggs AE, Slovic J, Thompson KN, Bhandary L, Martin SS. Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment. Cancer Res 2014;74:1250-60. [PMID: 24371229 DOI: 10.1158/0008-5472.CAN-13-1778] [Cited by in Crossref: 59] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
221 Lünenbürger H, Lanvers-Kaminsky C, Lechtape B, Frühwald MC. Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines. Anticancer Drugs 2010;21:514-22. [PMID: 20147838 DOI: 10.1097/CAD.0b013e3283375d5c] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
222 Shehzad A, Lee J, Huh TL, Lee YS. Curcumin induces apoptosis in human colorectal carcinoma (HCT-15) cells by regulating expression of Prp4 and p53. Mol Cells 2013;35:526-32. [PMID: 23686430 DOI: 10.1007/s10059-013-0038-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]